NCT02592408View on ClinicalTrials.gov

A Study to Assess Current Standard Malaria Treatment Guidelines in the Republic of the Sudan

PHASE4CompletedINTERVENTIONAL
Enrollment

320

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Malaria
Interventions
DRUG

ASP

3 days of artesunate sulfadoxine/pyrimethamine on days 0-2

DRUG

SDPQ

single dose primaquine on day 2

DRUG

14DPQ

14 day primaquine starting on day 2

DRUG

14DPQ on Day 42

14 day primaquine starting on day 42

Trial Locations (2)

11111

Gizeria Slang Hospital, Khartoum

31112

New Halfa Hospital, New Halfa

All Listed Sponsors
collaborator

University of Khartoum

OTHER

lead

Menzies School of Health Research

OTHER

NCT02592408 - A Study to Assess Current Standard Malaria Treatment Guidelines in the Republic of the Sudan | Biotech Hunter | Biotech Hunter